E167K polymorphism of TM6SF2 gene affects cell cycle of hepatocellular carcinoma cell HEPA 1-6
Abstract Background Some studties reported that the polymorphism of TM6SF2 gene E167K affects the occurrence and the progression of hepatocytes carcinoma (hepatocellular, HCC). In oeder to investigate the effects of the polymorphism of TM6SF2 gene E167K in the pathogenesis of HCC, we explored its in...
Main Authors: | Shuixian Du, Linlin Lu, Yingxia Miao, Wenwen Jin, Changfei Li, Yongning Xin, Shiying Xuan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-04-01
|
Series: | Lipids in Health and Disease |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12944-017-0468-8 |
Similar Items
-
Independent and joint correlation of PNPLA3 I148M and TM6SF2 E167K variants with the risk of coronary heart disease in patients with non-alcoholic fatty liver disease
by: Jian-Ting Wu, et al.
Published: (2020-02-01) -
The impact of polymorphism in PNPLA3 and TM6SF2 genes on the susceptibility and survival of hepatitis C-related hepatocellular carcinoma
by: Samar Samir Youssef, et al.
Published: (2022-09-01) -
Myeloid <i>TM6SF2</i> Deficiency Inhibits Atherosclerosis
by: Wenzhen Zhu, et al.
Published: (2022-09-01) -
Expression and Clinical Significance of TM9SF3 in Lung Adenocarcinoma
by: YU Hualin, et al.
Published: (2022-11-01) -
TM6SF2 and MAC30, new enzyme homologues in sterol metabolism and common metabolic disease.
by: Luis eSanchez-Pulido, et al.
Published: (2014-12-01)